Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 6503

2.

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.

Sriprayoon T, Mahidol C, Ungtrakul T, Chun-On P, Soonklang K, Pongpun W, Laohapand C, Dechma J, Pothijaroen C, Auewarakul C, Tanwandee T.

Hepatol Res. 2016 May 13. doi: 10.1111/hepr.12743. [Epub ahead of print]

PMID:
27176630
3.

Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.

Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.

PMID:
27149138
4.

2014 French guidelines for hepatitis B and C screening.A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.

Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y; Viral Hepatitis Testing Experts group.

Liver Int. 2016 Apr 4. doi: 10.1111/liv.13135. [Epub ahead of print]

PMID:
27043826
5.

Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?

Murunga E, Andersson M, Rensburg Cv.

Scand J Gastroenterol. 2016 Jul;51(7):814-8. doi: 10.3109/00365521.2016.1157888. Epub 2016 Mar 22.

PMID:
27000683
6.

[What is new in . . . Infectious diseases: Advancements and setbacks].

Tattevin P.

Rev Prat. 2015 Dec;65(10):1295-8. French. No abstract available.

PMID:
26979027
7.

[A needlestick injury - what next?].

Wicker S, Rabenau HF.

MMW Fortschr Med. 2015 Nov 5;157(19):49-50. German. No abstract available.

PMID:
26953410
8.

Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and Rilpivirine.

Khatri A, Dutta S, Dunbar M, Podsadecki T, Trinh R, Awni W, Menon R.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2965-71. doi: 10.1128/AAC.02605-15. Print 2016 May.

PMID:
26953200
9.

Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Hsu DC, Sereti I.

Drugs. 2016 Apr;76(5):533-49. doi: 10.1007/s40265-016-0546-7.

PMID:
26915027
10.

Direct anti-HCV agents.

Zhang X.

Acta Pharm Sin B. 2016 Jan;6(1):26-31. doi: 10.1016/j.apsb.2015.09.008. Epub 2015 Nov 24. Review.

12.

Sequential Therapy with PEG-IFN alpha-2a and Tenofovir in a Hepatitis B Virus-Infected African Man.

Cainelli F, Vento S.

Isr Med Assoc J. 2015 Dec;17(12):790. No abstract available.

13.

Treatment of chronic hepatitis B patients with tyrosine-methionine-aspartate-aspartate mutations.

Calica Utku A, Karabay O.

World J Gastroenterol. 2016 Jan 28;22(4):1727-8. doi: 10.3748/wjg.v22.i4.1727.

14.

Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.

Thenin-Houssier S, de Vera IM, Pedro-Rosa L, Brady A, Richard A, Konnick B, Opp S, Buffone C, Fuhrmann J, Kota S, Billack B, Pietka-Ottlik M, Tellinghuisen T, Choe H, Spicer T, Scampavia L, Diaz-Griffero F, Kojetin DJ, Valente ST.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2195-208. doi: 10.1128/AAC.02574-15. Print 2016 Apr.

PMID:
26810656
15.

[Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].

Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR, Biwolé Sida M.

Transfus Clin Biol. 2016 Jan 11. pii: S1246-7820(15)00438-3. doi: 10.1016/j.tracli.2015.11.008. [Epub ahead of print] French.

PMID:
26791918
16.

[Hepatitis C genotype 1. Harvoni and Holkira Pak reimbursed?].

Sabourin G.

Perspect Infirm. 2015 Nov-Dec;12(5):60. French. No abstract available.

PMID:
26730433
17.

Measuring the potential role of frailty in apparent declining efficacy of HIV interventions.

Hardnett FP, Rose CE.

HIV Clin Trials. 2015 Nov;16(6):219-27. doi: 10.1080/15284336.2015.1123944. Epub 2015 Dec 12.

18.

GENOMIC ANALYSIS OF HEPATITIS B VIRUS STRAINS INFECTING ROMANIAN PATIENTS.

Dinu S, Târdei G, Ceausu E, Moţoc A, Oprea C, Ungureanu E, Ene L, Duiculescu D, Cioflec DB, Oprişan G.

Roum Arch Microbiol Immunol. 2015 Jan-Jun;74(1-2):18-25.

PMID:
26727850
19.

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?

Mohr R, Schierwagen R, Schwarze-Zander C, Boesecke C, Wasmuth JC, Trebicka J, Rockstroh JK.

Medicine (Baltimore). 2015 Dec;94(50):e2127. doi: 10.1097/MD.0000000000002127.

20.

Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort.

Tilley DM, Griggs E, Hoy J, Wright ST, Woolley I, Burke M, O'Connor CC; Australian HIV Observational Database (AHOD).

AIDS Care. 2015;27(11):1410-7. doi: 10.1080/09540121.2015.1113227.

PMID:
26679270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk